logo
  Join        Login             Stock Quote

Teva (TEVA) Guides 2013 Below Market Expectations

 November 30, 2012 07:29 AM
 


(By Balachander) Teva Pharmaceutical Industries Ltd (NASDAQ: TEVA) issued its financial forecast for year ending December 2013, trailing market expectations.

The Israel-based generic drugs developer expects non-GAAP earnings per share (EPS) in the range of $4.85 to $5.15, on net revenue between $19.5 billion and $20.5 billion.

Wall Street analysts, on average, expect EPS of $5.65 on revenue of $20.82 billion.

2013 sales outlook consists of total U.S. net revenue of $10 billion to $10.6 billion, total European revenue of $5.5 billion to $6.1 billion, and total rest of the world net revenue of $3.7 billion to $4.3 billion, Teva said.

[Related -Invest In Stocks With A Margin Of Safety To Reduce Risk And Enhance Returns]

The company expects non-GAAP gross profit margin between 59 percent and 61 percent for the next year.

Early November, Teva posted a loss for the third quarter due to a provision for loss contingency of $670 million and impairments of $481 million. Its non-GAAP earnings increased and revenue grew 14.5 percent.

For the year 2012, the company expects non-GAAP EPS between $5.32 and $5.38 on net revenue of $20.1 billion and $20.7 billion. Analysts expect EPS of $5.36 on revenue of $20.36 billion.

American depositary receipts (ADR) of TEVA ended at $40.22 on Thursday.

iOnTheMarket Premium
Advertisement

Advertisement


Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 

rss feed

Latest Stories

article imageInitial Jobless Claims Rose Unexpectedly

Claims unexpectedly rose in the latest report through last weekend to breach 300,000 for the first time read on...

article imageAll Quiet on the Record High Front

What can we glean from the media’s lack of attention to the market’s recent record read on...

article imageThe Chip Maker Short Sellers Should Be Watching

Investing in semiconductor stocks is always tricky. Industry cycles can lead to bumps in the road for the read on...

article imageChicago Fed: US Economic Growth Slowed In October

The pace of US growth slowed more than expected in October, according to this morning’s update of the read on...

Advertisement
Popular Articles

Advertisement
Daily Sector Scan
Partner Center



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.